Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Patient Compliance × Patient Navigation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 3 Lung Neoplasms 2 Uterine Cervical Neoplasms 1 Tobacco Use 1 Smoking 1 Patient Compliance 1 Papillomavirus Infections 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma 1 Head and Neck Neoplasms 1

Interventions

beta-Aminoethyl Isothiourea 1 Trastuzumab 1 Patient Navigation 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Lapatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02553538 2018-03-26

Improving Comprehensive Cancer Screening Among Vulnerable Patients Using Patient Navigation

Massachusetts General Hospital

Phase NA Completed

1,612 enrolled 13 charts

Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡